Correlation of age-specific phenylalanine levels with intellectual outcome in patients with phenylketonuria

Journal of Inherited Metabolic Disease

Volumn 34, Issue 4, 2011, Pages 963-971

  Viau, Krista S ^a,b,c   Wengreen, Heidi J ^b   Ernst, Sharon L ^a,c   Cantor, Nancy L ^c   Furtado, Larissa V ^a   Longo, Nicola ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UTAH STATE UNIVERSITY   (United States)

^c PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

AGE; ARTICLE; BLOOD SAMPLING; CHILD; COMPREHENSION; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; INTELLIGENCE; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; MONITORING; PATIENT COMPLIANCE; PERCEPTION; PHENYLKETONURIA; PRESCHOOL CHILD; PROBABILITY; PSYCHOMETRY; SCHOOL CHILD; SKILL; SOCIAL LIFE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTELLIGENCE; LONGITUDINAL STUDIES; MALE; PHENYLALANINE; PHENYLKETONURIAS; PROGNOSIS; YOUNG ADULT;

EID: 79961171491     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9329-1     Document Type: Article

References (46)

1. V Anastasoaie L Kurzius P Forbes S Waisbren 2008 Stability of blood phenylalanine levels and IQ in children with phenylketonuria Mol Genet Metab 95 17 20 18703366 10.1016/j.ymgme.2008.06.014 1:CAS:528:DC%2BD1cXhtFCgtbnM
2. PJ Anderson V Leuzzi 2010 White matter pathology in phenylketonuria Mol Genet Metab 99 S3 S9 20123467 10.1016/j.ymgme.2009.10.005 1:CAS:528: DC%2BD1MXhsFyntbfI
3. PJ Anderson SJ Wood DE Francis L Coleman V Anderson A Boneh 2007 Are neuropsychological impairments in children with early-treated phenylketonuria related to white matter abnormalities or elevated phenylalanine levels? Dev Neuropsychol 32 645 668 17931123 10.1080/87565640701375963 (Pubitemid 47493428)
4. KM Antshel 2010 ADHD, learning, and academic performance in phenylketonuria Mol Genet Metab 99 S52 S58 20123471 10.1016/j.ymgme.2009.09.013 1:CAS:528:DC%2BD1MXhsFynur7O
5. KM Antshel SE Waisbren 2003 Timing is everything: executive functions in children exposed to elevated levels of phenylalanine Neuropsychology 17 458 468 12959512 10.1037/0894-4105.17.3.458 (Pubitemid 37013157)
6. C Azen R Koch E Friedman E Wenz K Fishler 1996 Summary of findings from the United States Collaborative Study of children treated for phenylketonuria Eur J Pediatr 155 S29 S32 8828605 10.1007/BF03036507
7. HK Berry DJ O'Grady LJ Perlmutter MK Bofinger 1979 Intellectual development and academic achievement of children early treated for phenylketonuria Dev Med Child Neurol 21 311 320 467815 10.1111/j.1469-8749.1979. tb01623.x 1:STN:280:DyaE1M3jsleitg%3D%3D (Pubitemid 10223511)
8. VL Brumm C Azen RA Moats, et al. 2004 Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review J Inherit Metab Dis 27 549 566 15669671 10.1023/B:BOLI.0000042985.02049. ff 1:STN:280:DC%2BD2M%2Fkt1ahug%3D%3D (Pubitemid 39295097)
9. J Burgard 2000 Development of intelligence in early treated phenylketonuria Eur J Pediatr 159 S74 S79 11043149 10.1007/PL00014388
10. P Burgard HJ Bremer P Buhrdel, et al. 1997 Rationale for the German recommendations for phenylalanine level control in phenylketonuria Eur J Pediatr 158 46 54 10.1007/s004310051008 (Pubitemid 29143579)
11. Burgard P, Xiaoping L, Hoffmann GF (2009) Phenylketonuria. In: Sarafoglou K, Hoffman GF, Roth KS (eds) Pediatric Endocrinology and Inborn Errors of Metabolism. McGraw Hill Companies, New York, pp 163-168
12. P Chang RM Gray LL O'Brien 2000 Patterns of academic achievement among patients treated early with phenylketonuria Eur J Pediatr 159 S96 S99 11043153 10.1007/PL00014394
13. S Channon C Mockler P Lee 2005 Executive functioning and speed of processing in phenylketonuria Neuropsychology 19 679 686 16187886 10.1037/0894-4105.19.5.679 (Pubitemid 41429115)
14. S Channon G Goodman S Zlotowitz C Mockler PJ Lee 2009 Effects of dietary management of phenylketonuria on long-term cognitive outcome Arch Dis Child 2 213 218 (Pubitemid 46423789)
15. MA Cleary JH Walter JE Wrath JPR Jenkins 1995 Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change J Pediatr 127 251 255 7636650 10.1016/S0022-3476(95)70303-9 1:STN:280:DyaK2MzmtlGqug%3D%3D
16. LMJ de Sonneville SCJ Huijbregts FJ van Spronsen PH Verkerk JA Sergeant R Licht 2010 Event-related potential correlates of selective processing in early- and continuously-treated children with phenylketonuria: effects of concurrent phenylalanine level and dietary control Mol Genet Metab 99 S10 S17 20123462 10.1016/j.ymgme.2009.10.177
17. CA Dyer 2000 Comments on the neuropathology of phenylketonuria Eur J Pediatr 159 Suppl 2 S107 S108 11043155 10.1007/PL00014369
18. GM Enns R Koch V Brumm E Blakely R Suter E Jurecki 2010 Suboptimal outcomes in patients with PKU treated with diet alone: revisiting the evidence Mol Genet Metab 101 99 109 20678948 10.1016/j.ymgme.2010.05.017 1:CAS:528:DC%2BC3cXht1CmtbjN
19. F Feillet A MacDonald D Hartung B Burton 2010 Outcomes beyond phenylalanine: an international perspective Mol Genet Metab 99 S79 S85 20123476 10.1016/j.ymgme.2009.09.015 1:CAS:528:DC%2BD1MXhsFynur%2FO
20. R Feldmann J Denecke M Pietsch M Grenzebach J Weglage 2002 Phenylketonuria: no specific frontal lobe-dependent neuropsychological deficits in early-treated patients in comparison with diabetics Pediatr Res 51 761 765 12032274 (Pubitemid 34547342)
21. K Fishler C Azen R Henderson EG Friedman R Koch 1987 Psychoeducational findings among children treated for phenylketonuria Am J Ment Defic 92 65 73 3618658 1:STN:280:DyaL2s3ps1Wiuw%3D%3D (Pubitemid 17109726)
22. Flanagan DP, Kaufman AS (2009) Essentials of WISC-IV Assessment. Wiley, Hoboken, NJ
23. R Gassio R Artuch MA Vilaseca, et al. 2005a Cognitive functions in classic phenylketonuria and mild hyperphenylalaninaemia: experience in a pediatric population Dev Med Child Neurol 47 443 448 10.1017/S0012162205000861 (Pubitemid 40895408)
24. R Gassio E Fuste A Lopez-Sala R Artuch MA Vilaseca J Campistol 2005b School performance in early and continuously treated phenylketonuria Pediatr Neurol 33 267 271 10.1016/j.pediatrneurol.2005.05.003 (Pubitemid 41382505)
25. JK Gentile AE Ten Hoedt AM Bosch 2010 Psychosocial aspects of PKU: hidden disabilities - a review Mol Genet Metab 99 S64 S67 20123473 10.1016/j.ymgme.2009.10.183 1:CAS:528:DC%2BD1MXhsFynur7K
26. CO Gregory C Yu RH Singh 2007 Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods Genet Med 9 761 765 18007145 10.1097/GIM.0b013e318159a355 1:CAS:528:DC%2BD2sXhtlSmtbvE (Pubitemid 350129411)
27. D Janzen M Nguyen 2010 Beyond executive function: non-executive cognitive abilities in individuals with PKU Mol Genet Metab 99 S47 S51 20123470 10.1016/j.ymgme.2009.10.009 1:CAS:528:DC%2BD1MXhsFynur7N
28. Kaufman AS, Lichtenberger EO (1999) Essentials of WAIS-III Assessment. JohnWiley & Sons, Inc., New York
29. V Leuzzi M Pansini E Sechi 2004 Executive impairment in early-treated PKU subjects with normal mental development J Inherit Metab Dis 27 115 125 15159642 10.1023/B:BOLI.0000028781.94251.1f 1:STN:280:DC%2BD2c3lvF2gtA%3D%3D (Pubitemid 38756327)
30. JJ Moyle AM Fox M Arthur M Byneveldt JR Burnett 2007a Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU Neuropsychol Rev 17 91 101 10.1007/s11065-007-9021-2 1:STN:280:DC%2BD2szjvFKhsw%3D%3D (Pubitemid 46889563)
31. JJ Moyle AM Fox M Bynevelt M Arthur JR Burnett 2007b A neuropsychological profile of off-diet adults with phenylketonuria J Clin Exp Neuropsychol 29 436 441 10.1080/13803390600745829 1:STN:280:DC%2BD2s3oslKlsg%3D%3D (Pubitemid 46763624)
32. NIH 2000 Phenylketonuria (PKU): screening and management NIH Consens Statement 17 1 33
33. D Rice S Barone 2000 Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models Environ Health Perspect 108 S511 S533 10.2307/3454543
34. J Smith M Beasley 1989 Intelligence and behavior in children with early treated phenylketonuria. A report from the MRC/DHSS phenylketonuria register Eur J Clin Nutr 43 S1 S5
35. HA Solan 1987 The effects of visual-spatial and verbal skills on written and mental arithmetic J Am Optom Assoc 58 88 94 3819301 1:STN:280: DyaL2s7jvV2qsA%3D%3D
36. BA Stemerdink AF Kalverboer JJ Van der Meere 2000 Behavior and school achievement in patients with early and continuously treated phenylketonuria J Inherit Metab Dis 23 548 562 11032330 10.1023/A:1005669610722 1:STN:280:DC%2BD3cvnvFOgtg%3D%3D
37. KH VanZutphen W Packman L Sporri 2007 Executive functioning in children and adolescents with phenylketonuria Clin Genet 72 13 18 17594394 10.1111/j.1399-0004.2007.00816.x 1:STN:280:DC%2BD2sznvVWmsA%3D%3D (Pubitemid 47010142)
38. MA Vilaseca N Lambruschini L Gomez-Lopez 2010 Quality of dietary control in phenylketonuric patients and its relationship with general intelligence Nutr Hosp 25 60 66 20204257 1:STN:280:DC%2BC3c3nvVGntQ%3D%3D
39. S Waisbren K Noel K Fahrbach, et al. 2007 Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis Mol Genet Metab 92 63 70 17591452 10.1016/j.ymgme.2007.05.006 1:CAS:528:DC%2BD2sXhtVWmtL%2FJ (Pubitemid 47361886)
40. JH Walter FJ White A MacDonald 2002 How practical are recommendations for dietary control in phenylketonuria? Lancet 360 55 57 12114043 10.1016/S0140-6736(02)09334-0 1:STN:280:DC%2BD38zntFKjtA%3D%3D (Pubitemid 34756494)
41. R Wappner S Cho RA Kronmal V Schuett MR Seashore 1999 Management of phenylketonuria for optimal outcome: a review of guidelines for phenylketonuria management and a report of surveys of parents, patients, and clinic directors Pediatrics 104 e68 10586002 10.1542/peds.104.6.e68 1:STN:280: DC%2BD3c%2FlsV2gsw%3D%3D
42. Wechsler D (2003) WISC - IV Australian Administration and Scoring Manual. Harcourt Assessment
43. J Weglage B Funders B Wilken, et al. 1992 Psychological and social findings in adolescents with phenylketonuria Eur J Pediatr 151 522 525 1396915 10.1007/BF01957759 1:STN:280:DyaK3s%2FhtFeqtg%3D%3D
44. U Wendel K Ullrich H Schimdt U Batzler 1990 Six-year follow up of phenylalanine intakes and plasma phenylalanine concentrations Eur J Pediatr 149 Suppl 1 S13 S16 2091925 10.1007/BF02126293
45. DA White L Tabor Connor B Nardos 2010 Age-related decline in the microstructural integrity of white matter in children with early- and continuously-treated PKU: a DTI study of corpus callosum Mol Genet Metab 99 S41 S46 20123469 10.1016/j.ymgme.2009.09.016 1:CAS:528:DC%2BD1MXhsFyntbfE
46. Williams PE, Weiss LG, Folfhus EL (2003) WISC-IV Technical Manual #2. The Psychological Corporation